Literature DB >> 21316181

Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women.

Arwen H Pieterse1, Margreet G E M Ausems, Peter Spreeuwenberg, Sandra van Dulmen.   

Abstract

OBJECTIVE: To evaluate outcomes of breast cancer genetic counseling in women with and without breast cancer.
METHODS: Seventy-seven first-time attendees (n=44 affected) completed questionnaires assessing cognitions (risk accuracy, knowledge, perceived personal control [PPC]) and distress (state anxiety [STAI], cancer-related stress reactions [IES]) from immediately before to immediately and six months after completing counseling. Data were analyzed using multilevel repeated measures and trend analyses.
RESULTS: In affected counselees, mean cognitions did not significantly differ over time, anxiety significantly decreased, and IES levels were increased immediately post-counseling. In unaffected counselees, cognitions significantly improved over time except for knowledge. Distress levels showed similar patterns as in affected women. Improvements in cognitions and distress were significantly smaller in affected versus unaffected women.
CONCLUSION: Overall, counseling educates women about breast cancer risk and alleviates their anxiety. Importantly, benefits gained at immediate follow-up seem maintained over time. PRACTICE IMPLICATION: Affected women seem to benefit less from counseling. Counselors may need to devote more effort into educating these women and addressing their anxieties. Future studies should confirm the unexpected finding that cancer-related distress increased immediately post-counseling.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21316181     DOI: 10.1016/j.pec.2011.01.017

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  12 in total

1.  A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.

Authors:  Akke Albada; Sandra van Dulmen; Dick Lindhout; Jozien M Bensing; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 2.  A Rapid Systematic Review of Outcomes Studies in Genetic Counseling.

Authors:  Lisa Madlensky; Angela M Trepanier; Deborah Cragun; Barbara Lerner; Kristen M Shannon; Heather Zierhut
Journal:  J Genet Couns       Date:  2017-02-06       Impact factor: 2.537

3.  Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands?

Authors:  Akke Albada; Julie Werrett; Sandra Van Dulmen; Jozien M Bensing; Cyril Chapman; Margreet G E M Ausems; Alison Metcalfe
Journal:  J Community Genet       Date:  2011-08-18

4.  Inappropriate Metacognitive Status Increases State Anxiety in Genetic Counseling Clients.

Authors:  Yuka Shibata; Masaaki Matsushima; Megumi Takeuchi; Momoko Kato; Ichiro Yabe
Journal:  Front Psychol       Date:  2022-05-12

5.  Psychiatric symptoms in a Spanish sample with hereditary cancer risk.

Authors:  Gema Costa-Requena; Mercedes Garcia-Garijo; Paula Richart-Aznar; Ángel Segura-Huerta
Journal:  J Community Genet       Date:  2022-02-08

6.  The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes.

Authors:  Nabil Amara; Jolyane Blouin-Bougie; Jalila Jbilou; Norrin Halilem; Jacques Simard; Réjean Landry
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

7.  Effect of pre-test genetic counseling for deaf adults on knowledge of genetic testing.

Authors:  Erin E Baldwin; Patrick Boudreault; Michelle Fox; Janet S Sinsheimer; Christina G S Palmer
Journal:  J Genet Couns       Date:  2011-08-05       Impact factor: 2.537

Review 8.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

9.  Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.

Authors:  Sari Lieberman; Ariela Tomer; Avi Ben-Chetrit; Oded Olsha; Shalom Strano; Rachel Beeri; Sivan Koka; Hila Fridman; Karen Djemal; Itzhak Glick; Todd Zalut; Shlomo Segev; Miri Sklair; Bella Kaufman; Amnon Lahad; Aviad Raz; Ephrat Levy-Lahad
Journal:  Genet Med       Date:  2016-12-08       Impact factor: 8.822

10.  Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.

Authors:  Akke Albada; Sandra van Dulmen; Henrietta Dijkstra; Ivette Wieffer; Arjen Witkamp; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2015-09-01       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.